🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This article by Ophthalmology Times Europe explains how researchers at NDCN are utilising a new cutting-edge technique, CRISPR, to combat age-related macular degeneration (AMD) – the leading cause of irreversible blindness in the world MacLaren Research Group Oxford 👇 tinyurl.com/ycknzxm3

Very proud of my supervisors MacLaren Research Group Oxford and Jasmina Kapetanovic on gene therapy panel of EURETINA 2024 (Barcelona, Spain).

Real-World 6-month outcomes in AMD and DMO after faricimab switch. From the Oxford Eye Hospital. nature.com/articles/s4143… Samantha de Silva Grace Borchert MacLaren Research Group Oxford Kanmin Xue Jasmina Kapetanovic #Ophthalmology

Our recent research group journal club (term 2024-25) in beautiful Christ church collage. MacLaren Research Group Oxford

Outcome measures in #Choroideremia clinical trial. CRF webinar with Amandeep Josan (PhD) research Optometrist working alongside Prof Robert MacLaren, University of Oxford Eye Hospital. MacLaren Research Group Oxford youtu.be/QD45VQh3EJM?fe…

1/2 Gene and cell engineering could bring new treatments for diseases caused by defective genes. Our 🌟Gene and Cell Therapy team🌟 is working on therapies for different conditions oxfordbrc.nihr.ac.uk/research-theme…

🚨DEADLINE EXTENDED to 22 November. Apply now 👇 tinyurl.com/evvdvffc MacLaren Research Group Oxford

📢FUNDED DPHIL OPPORTUNITY: Peptide-mediated delivery of CRISPR-Cas genome editors in the eye. MacLaren Research Group Oxford Jasmina Kapetanovic Apply before 3 December 2024👇 tinyurl.com/46dt4zhd

ICYMI - our own Prof Robert MacLaren (Gene & Cell Therapy Theme) named among world's top 100 ophthalmologists oxfordbrc.nihr.ac.uk/oxford-profess… MacLaren Research Group Oxford Nuffield Department of Clinical Neurosciences National Institute for Health and Care Research OUH The Ophthalmologist

Happy to share our blog post: Exploring real-world six-month outcomes in patients switched to faricimab for neovascular age-related macular degeneration and diabetic macular oedema communities.springernature.com/posts/explorin… Samantha de Silva Nuffield Department of Clinical Neurosciences OUH

Gene therapy for choroideremia: progress, potential and pitfalls Lessons learnt from CHM phase 3 clinical trial, encompassing optimal vector design, delivery techniques, patient selection criteria, and long-term safety profiles ⁦MacLaren Research Group Oxford⁩ search.app/9T5iPY9q9chsNk…

🔊 WE'RE HIRING: Laboratory Technician We're looking for experienced laboratory technicians to apply for an available post providing technical support for a biomedical research programme. Apply now: buff.ly/16MjOIy

Congratulations Professor MacLaren on being awarded the WCSM prestigious Silver (Fincham) Medal! abdo.org.uk/news/wcsm-awar…

New work led by Dr. Robert MacLaren (MacLaren Research Group Oxford) at Nuffield Department of Clinical Neurosciences has explored #CRISPR targeting of SNPs associated with age-related #MacularDegeneration in ARPE-19 cells. 👁️🧬 Read the Gene Therapy study: go.nature.com/42vHlT2

Exciting new job opportunity in NDCN ... Margaret Ogilvie's Professor of Ophthalmology at University of Oxford jobs.ac.uk/job/DMZ675/mar…

Annual MacLaren Lab Group Dinner at ARVO 2025. Great to see many familiar faces and share exciting updates!

ARVO 2025 Kwame, Grace, Cristina & Molly presenting posters

ARVO 2025 Shabnam, Olha, Imran & Aman presenting posters

ARVO 2025 Sylvia & Ben presenting posters